These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 11436120

  • 41. [Maternal biochemical screening -- an approach for genetic prevention. part 1. first and second trimester screening].
    Angelova L, Gadancheva V, Konstantinova D, Stoianova M, Hachmerian M, Yakov B, Kremenski I.
    Akush Ginekol (Sofiia); 2013; 52(5):8-13. PubMed ID: 24501862
    [Abstract] [Full Text] [Related]

  • 42. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency.
    Krantz DA, Hallahan TW, Orlandi F, Buchanan P, Larsen JW, Macri JN.
    Obstet Gynecol; 2000 Aug; 96(2):207-13. PubMed ID: 10908764
    [Abstract] [Full Text] [Related]

  • 43. Importance of the integrated test in the Down's syndrome screening algorithm.
    Springer D, Loucky J, Tesner P, Cutka D, Stejskal D, Gregor V, Zima T.
    J Med Screen; 2018 Sep; 25(3):114-118. PubMed ID: 29575979
    [Abstract] [Full Text] [Related]

  • 44. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
    Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH.
    BJOG; 2003 Mar; 110(3):281-6. PubMed ID: 12628268
    [Abstract] [Full Text] [Related]

  • 45. First trimester Down's syndrome screening shows high detection rate for trisomy 21, but poor performance in structural abnormalities--regional outcome results.
    Rissanen A, Niemimaa M, Suonpää M, Ryynänen M, Heinonen S.
    Fetal Diagn Ther; 2007 Mar; 22(1):45-50. PubMed ID: 17003556
    [Abstract] [Full Text] [Related]

  • 46. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 47. Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.
    Berry E, Aitken DA, Crossley JA, Macri JN, Connor JM.
    Br J Obstet Gynaecol; 1997 Jul; 104(7):811-7. PubMed ID: 9236646
    [Abstract] [Full Text] [Related]

  • 48. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
    Bestwick JP, Huttly WJ, Wald NJ.
    J Med Screen; 2008 Jul; 15(4):204-6. PubMed ID: 19106261
    [Abstract] [Full Text] [Related]

  • 49. Practical strategies in contingent sequential screening for Down syndrome.
    Benn P, Wright D, Cuckle H.
    Prenat Diagn; 2005 Aug; 25(8):645-52. PubMed ID: 16049988
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population.
    Leung TY, Spencer K, Leung TN, Fung TY, Lau TK.
    Fetal Diagn Ther; 2006 Aug; 21(1):140-3. PubMed ID: 16354992
    [Abstract] [Full Text] [Related]

  • 52. [Prenatal Down's syndrome screening at 10-14 weeks gestation using the combined nuchal translucency and maternal serum biochemistry: preliminary results of the first 358 cases].
    Maymon R, Bergman M, Segal S, Dreazen E, Weinraub Z, Herman A.
    Harefuah; 2001 Jul; 140(7):594-9, 679. PubMed ID: 11481959
    [Abstract] [Full Text] [Related]

  • 53. More invasive procedures are done to detect each case of Down's syndrome in younger women.
    Marttala J, Ranta JK, Kaijomaa M, Nieminen P, Laitinen P, Kokkonen H, Romppanen J, Hamalainen E, Kultti J, Tekay A, Ulander VM, Honkasalo T, Ryynanen M.
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):642-7. PubMed ID: 21355862
    [Abstract] [Full Text] [Related]

  • 54. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K, Crossley JA, Aitken DA, Nix AB, Dunstan FD, Williams K.
    Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
    [Abstract] [Full Text] [Related]

  • 55. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N, Egić A, Filimonović D, Marinković M, Damnjanović-Pazin B, Milovanović Z, Joksić I, Branković S, Lukić R, Mandić V, Cerović N, Mojović D, Plamenac S, Stanković M, Maglić D, Mikovć Z.
    Srp Arh Celok Lek; 2012 May; 140(9-10):606-11. PubMed ID: 23289277
    [Abstract] [Full Text] [Related]

  • 56. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study.
    Borrell A, Casals E, Fortuny A, Farre MT, Gonce A, Sanchez A, Soler A, Cararach V, Vanrell JA.
    Prenat Diagn; 2004 Jul; 24(7):541-5. PubMed ID: 15300745
    [Abstract] [Full Text] [Related]

  • 57. Prospective validation of first-trimester combined screening for trisomy 21.
    Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
    [Abstract] [Full Text] [Related]

  • 58. [Screening for Down's syndrome in the 10th to 13th week of pregnancy].
    Stejskal D, Brest'ak M, Hostlovská M.
    Ceska Gynekol; 1999 Sep; 64(5):309-12. PubMed ID: 11048413
    [Abstract] [Full Text] [Related]

  • 59. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
    Christiansen M, Nørgaard-Pedersen B.
    Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
    [Abstract] [Full Text] [Related]

  • 60. Uptake of prenatal screening for chromosomal anomalies: impact of test results in a previous pregnancy.
    Spencer K.
    Prenat Diagn; 2002 Dec; 22(13):1229-32. PubMed ID: 12478639
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.